Lv5
1135 积分 2022-03-31 加入
IL‐12 and the Antitumor Response: The Good, the Bad, and the Unknown
10天前
已完结
Integrin α11: Key Signaling Pathways and Tumor Dynamics
1个月前
已完结
Endosialin (CD248) Cancer Role and Therapeutics: 33 years on
1个月前
已完结
In Vivo Auto-tuning of Antibody–Drug Conjugate Delivery to Maximize Efficacy Using High-Avidity, Low-Affinity Antibodies
1个月前
已关闭
Reprogramming the tumor immune microenvironment via antibody-drug conjugates
1个月前
已完结
Abstract 5567:In vivoadministration of the STING agonist, JNJ-67544412, leads to complete regression of established murine subcutaneous tumors
2个月前
已关闭
Structure-guided computational design of novel polycyclic aromatic compounds as telomerase inhibitors for the treatment of cancer
3个月前
已完结
SIM0708, an antibody-drug conjugate (ADC) with half-life extended anti-IL-4 receptor a (IL-4Ra) antibody and glucocorticoid receptor modulator exhibits superior efficacy treating inflammatory diseases 4657
4个月前
已关闭
An In Vitro Model of Hematotoxicity: Differentiation of Bone Marrow–Derived Stem/Progenitor Cells into Hematopoietic Lineages and Evaluation of Lineage‐Specific Hematotoxicity
4个月前
已完结
An “Fc-Silenced” IgG1 Format With Extended Half-Life Designed for Improved Stability
5个月前
已完结
皖公网安备34019202002308
